Operational Excellence: Pharma’s Missed Opportunities by Thomas Friedli, University of St. Gallen and Prabir Basu published in March's edition of the Pharmaceutical Manufacturing Magazine (Link above to the article) is well worth a read.
It is drawn from a europe-wide benchmarking study conducted by the University of St. Gallen, Switzerland, and the International Association for Pharmaceutical Technology (APV). It reveals that an average pharmaceutical plant could save up to € 6.5 million per year by achieving the degree of operational excellence equivalent to that achieved by the top 10% of the sample. About 100 pharmaceutical manufacturing locations all over Europe were analyzed in this study.
No comments:
Post a Comment